CVS HEALTH Corp (CVS) Options Risk Score
Real-time risk analysis for CVS options traders — updated every 30 minutes.
Data last updated: 2026-07-23
Run a full CVS options risk analysis
See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.
Scan CVS Now — Free →
Is it risky to sell options on CVS HEALTH Corp (CVS) right now?
For a 4-week expiry, CVS HEALTH Corp (CVS) carries an options catalyst-risk score of 100 out of 100 (HIGH). The contributing signals are an upcoming earnings report, 2 recent news items, 10 active legal filings and 18 clinical-trial catalysts within the 4-week window. Anything at 70 or above counts as HIGH, meaning the premium on CVS is at least partly compensation for a scheduled event rather than pure time value. It says nothing about direction — only that something is on the calendar.
CVS shows an IV Rank of 42, near the low end of its one-year range — options are relatively cheap, which favours option buyers over sellers, with a current implied volatility of about 36%. IV Rank answers how CVS options are priced against their own history, which is the starting point for choosing between selling and buying premium.
The 2026-08-05 earnings report sits inside a standard monthly expiry for CVS, so implied volatility should stay bid into the date and drop sharply once it passes.
TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer